Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Cytokinetics to present at 2026 RBC Healthcare Conference, advancing cardiac drug pipeline.

Market News
12 May 2026
GlobeNewsWire
View Source
Neutral
pluang ai news

Cytokinetics announced its management will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on May 19, 2026. The company, specializing in cardiovascular biopharmaceuticals, is advancing several cardiac drugs including MYQORZO® (aficamten), approved for obstructive hypertrophic cardiomyopathy, and investigational drugs omecamtiv mecarbil and ulacamten for heart failure. Positive Phase 3 trial results for aficamten in non-obstructive hypertrophic cardiomyopathy are set to be presented soon, with ongoing discussions planned with regulatory authorities. The webcast of the event will be available on Cytokinetics' website for 90 days.

More News (CYTK)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App